MD Market Analysis

Overview

Fundamentals

P/E ratio11.43Forward 8.21
EPS (TTM)$2.0650.0% YoY
Profit margin9.0%HEALTHCARE
Market cap$1.93BSmall cap

Wall Street coverage

$23.17median target· current $7.71 (+200.5%)7 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
8.21
PEG ratio
0.24
P/B
2.20
P/S (TTM)
1.00
EV/EBITDA
7.84

Profitability & growth

ROE (TTM)
20.9%
Operating margin
9.8%
Revenue growth YoY
3.9%
Dividend yield
Beta
0.70
Last earnings
May 5, 2026 · Estimate $0.38 · Reported $0.44
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Mednax Inc

MEDNAX, Inc., provides neonatal, maternal-fetal, pediatric cardiology, and other pediatric subspecialties in the United States and Puerto Rico. The company is headquartered in Sunrise, Florida.

Classification

Exchange
NYSE
Country
USA
Currency
USD

Company profile

HQ
1301 CONCORD TERRACE, SUNRISE, FL
Fiscal year end
December
Latest quarter
Mar 31, 2026
Market cap$1.93B
Shares outstanding$82.1M
52W high$24.99
52W low$11.84

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer